Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Moffitt Cancer Center

InstitutionResearch output, impact & collaborations

Moffitt Cancer Center is a research organisation in Tampa, US. OpenAlex records 37,929 works and 4,553,201 citations for it. 7,250 researchers list it as their most recent affiliation.

37,929
Works
4,553,201
Citations
7,250
Researchers
65.6
Avg h-index

How has Moffitt Cancer Center's publication output changed over time?

ScholarIQpublication output · 2003–2020

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2020.

1
1
2
4
2
1
1
2003200920102017201820192020

Who are the most-cited researchers behind Moffitt Cancer Center?

ScholarIQtop researchers by citations
1
Jhanelle E. Gray · Lung Cancer Treatments and Mutations
737 works34,479 citations
2
Eric B. Haura · Lung Cancer Treatments and Mutations
997 works25,585 citations
3
Jonathan Strosberg · Neuroendocrine Tumor Research Advances
430 works21,892 citations
4
Larry K. Kvols · Neuroendocrine Tumor Research Advances
276 works18,607 citations
5
Alberto Chiappori · Lung Cancer Research Studies
257 works16,930 citations

What are the most-cited papers on Moffitt Cancer Center?

ScholarIQmost cited works
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino
New England Journal of Medicine. 20186,696 CitationsOPEN ACCESS
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang, Jonathan Harris, Richard Wheeler, Randal S. Weber, David I. Rosenthal, Phuc Félix Nguyen‐Tan, William H. Westra, Christine H. Chung, Richard C. Jordan, Charles Lu, Harold Kim, Rita Axelrod, C. Craig Silverman, Kevin P. Redmond, Maura L. Gillison
New England Journal of Medicine. 20106,573 CitationsOPEN ACCESS
Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer
Jean‐Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata, Isamu Okamoto, Caicun Zhou, Byoung Chul Cho, Ying Cheng, Eun Kyung Cho, Pei Jye Voon, David Planchard, Wu‐Chou Su, Jhanelle E. Gray, Siow Ming Lee, Rachel Hodge, Marcelo Marotti, Yuri Rukazenkov, Suresh S. Ramalingam
New England Journal of Medicine. 20175,376 CitationsOPEN ACCESS
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
Scott Antonia, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki Hyeong Lee, Maike de Wit, Byoung Chul Cho, Maryam Bourhaba, Xavier Quantin, Takaaki Tokito, Tarek Mekhail, David Planchard, Young‐Chul Kim, Christos S. Karapetis, Sandrine Hiret, Gyula Ostoros, Kaoru Kubota, Jhanelle E. Gray, Luis Paz‐Ares, Javier de Castro, Catherine Wadsworth, Giovanni Melillo, Haiyi Jiang, Yifan Huang, Phillip A. Dennis, Mustafa Özgüroğlu
New England Journal of Medicine. 20174,592 CitationsOPEN ACCESS
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak
Journal of Clinical Oncology. 20094,587 CitationsOPEN ACCESS

Who collaborates most closely around Moffitt Cancer Center?

ScholarIQco-authorship network
United States
86%
Australia
14%

How much of the research on Moffitt Cancer Center is open access?

ScholarIQopen access share
92%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
0%
Bronze
67%
Closed
8%

Related on ScholarIQ

CAR-T cell therapy research
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Acute Myeloid Leukemia Research
Top Topic
Cancer Genomics and Diagnostics
Top Topic
Lymphoma Diagnosis and Treatment
Top Topic
Immunotherapy and Immune Responses
Top Topic
470M+ articles · free account